{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:13:41Z","timestamp":1791828821680,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA189823"],"award-info":[{"award-number":["UG1CA189823"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA233196"],"award-info":[{"award-number":["UG1CA233196"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA233331"],"award-info":[{"award-number":["UG1CA233331"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA232760"],"award-info":[{"award-number":["UG1CA232760"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA233320"],"award-info":[{"award-number":["UG1CA233320"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA189825"],"award-info":[{"award-number":["UG1CA189825"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.maturitas.2020.10.018","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T11:51:07Z","timestamp":1606909867000},"page":"37-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors"],"prefix":"10.1016","volume":"144","author":[{"given":"Allison M.","family":"Quick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Dockter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Le-Rademacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Salani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hundley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Terstriep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Streicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Faubion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Loprinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenell S.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Lustberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.maturitas.2020.10.018_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/13697137.2013.871696","article-title":"Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause","volume":"17","author":"Nappi","year":"2014","journal-title":"Climacteric J. Int. Menopause Soc."},{"issue":"3","key":"10.1016\/j.maturitas.2020.10.018_bib0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jsxm.2017.01.011","article-title":"The women\u2019s EMPOWER survey: women\u2019s knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate","volume":"14","author":"Krychman","year":"2017","journal-title":"J. Sex. Med."},{"issue":"3","key":"10.1016\/j.maturitas.2020.10.018_bib0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.maturitas.2014.07.013","article-title":"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and the North American Menopause Society","volume":"79","author":"Portman","year":"2014","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.maturitas.2020.10.018_bib0020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/GRF.0000000000000381","article-title":"Menopausal hormone therapy in gynecologic Cancer survivors: a review of the evidence and practice recommendations","volume":"61","author":"Kapoor","year":"2018","journal-title":"Clin. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.maturitas.2020.10.018_bib0025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ygyno.2017.06.013","article-title":"Management of menopausal symptoms in women with gynecologic cancers","volume":"146","author":"Del Carmen","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.maturitas.2020.10.018_bib0030","first-page":"186","article-title":"Pelvic radiotherapy and sexual function in women","volume":"4","author":"Jensen","year":"2015","journal-title":"Transl. Androl. Urol."},{"issue":"4","key":"10.1016\/j.maturitas.2020.10.018_bib0035","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1743-6109.2006.00204.x","article-title":"Sexual dysfunction in patients with gynecologic neoplasms: a retrospective pilot study","volume":"3","author":"Amsterdam","year":"2006","journal-title":"J. Sex. Med."},{"issue":"1","key":"10.1016\/j.maturitas.2020.10.018_bib0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/S1677-5538.IBJU.2013.01.07","article-title":"Treatments for invasive carcinoma of the cervix: what are their impacts on the pelvic floor functions?","volume":"39","author":"Noronha","year":"2013","journal-title":"Int. Braz J. Urol"},{"issue":"7","key":"10.1016\/j.maturitas.2020.10.018_bib0045","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/GME.0000000000000921","article-title":"The 2017 hormone therapy position statement of the North American Menopause Society","volume":"24","year":"2017","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.maturitas.2020.10.018_bib0050","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ijrobp.2010.02.058","article-title":"Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer","volume":"80","author":"Friedman","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.maturitas.2020.10.018_bib0055","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7513610","article-title":"Impact of Ospemifene on quality of life and sexual function in young survivors of cervical Cancer: a prospective study","volume":"2017","author":"De Rosa","year":"2017","journal-title":"Biomed Res. Int."},{"issue":"6","key":"10.1016\/j.maturitas.2020.10.018_bib0060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/GCO.0000000000000230","article-title":"The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy","volume":"27","author":"Stefano","year":"2015","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.maturitas.2020.10.018_bib0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.maturitas.2014.02.015","article-title":"Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial","volume":"78","author":"Portman","year":"2014","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.maturitas.2020.10.018_bib0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2020.01.035","volume":"157","author":"Sinno","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.maturitas.2020.10.018_bib0075","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clbc.2017.05.008","article-title":"Vaginal atrophy in breast Cancer survivors: attitude and approaches among oncologists","volume":"17","author":"Biglia","year":"2017","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.maturitas.2020.10.018_bib0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.maturitas.2017.07.007","article-title":"CO2-laser for the genitourinary syndrome of menopause. How many laser sessions?","volume":"104","author":"Athanasiou","year":"2017","journal-title":"Maturitas"},{"issue":"7","key":"10.1016\/j.maturitas.2020.10.018_bib0085","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/GME.0000000000000839","article-title":"Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes","volume":"24","author":"Sokol","year":"2017","journal-title":"Menopause (New York, NY)."},{"issue":"3","key":"10.1016\/j.maturitas.2020.10.018_bib0090","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.maturitas.2014.12.006","article-title":"Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser","volume":"80","author":"Perino","year":"2015","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.maturitas.2020.10.018_bib0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/13697137.2014.899347","article-title":"A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study","volume":"17","author":"Salvatore","year":"2014","journal-title":"Climacteric: J. Int. Menopause Soc."},{"key":"10.1016\/j.maturitas.2020.10.018_bib0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.maturitas.2016.09.012","article-title":"Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: an observational study","volume":"94","author":"Pitsouni","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2020.10.018_bib0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejogrb.2017.03.036","article-title":"Safety and long-term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopause","volume":"213","author":"Behnia-Willison","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.maturitas.2020.10.018_bib0110","article-title":"Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study","author":"Filippini","year":"2019","journal-title":"Menopause (New York, NY)."},{"issue":"6","key":"10.1016\/j.maturitas.2020.10.018_bib0115","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/GME.0000000000001053","article-title":"Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study","volume":"25","author":"Pagano","year":"2017","journal-title":"Menopause (New York, NY)."},{"issue":"4","key":"10.1016\/j.maturitas.2020.10.018_bib0120","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00404-016-4118-6","article-title":"Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors","volume":"294","author":"Pieralli","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.maturitas.2020.10.018_bib0125","first-page":"3669","article-title":"Fractional CO2 Laser Therapy for Genitourinary Syndrome of Menopause for Breast Cancer Survivors","volume":"28","author":"Quick","year":"2020","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.maturitas.2020.10.018_bib0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/GME.0000000000001416","article-title":"A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the VeLVET Trial","volume":"27","author":"Paraiso","year":"2020","journal-title":"Menopause (New York, NY)."},{"issue":"2","key":"10.1016\/j.maturitas.2020.10.018_bib0135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11764-016-0585-9","article-title":"Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors","volume":"11","author":"Carter","year":"2017","journal-title":"J. Cancer Survivorship Res. Pract."},{"issue":"1","key":"10.1016\/j.maturitas.2020.10.018_bib0140","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jsxm.2016.11.317","article-title":"Validation of clinical tools for vaginal and vulvar symptom assessment in Cancer patients and survivors","volume":"14","author":"Eaton","year":"2017","journal-title":"J. Sex. Med."},{"issue":"2","key":"10.1016\/j.maturitas.2020.10.018_bib0145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J. Sex Marital Ther."},{"issue":"18","key":"10.1016\/j.maturitas.2020.10.018_bib0150","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1002\/cncr.26739","article-title":"Psychometric validation of the female sexual function index (FSFI) in cancer survivors","volume":"118","author":"Baser","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.maturitas.2020.10.018_bib0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/nau.1930140206","article-title":"Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group","volume":"14","author":"Uebersax","year":"1995","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.maturitas.2020.10.018_bib0160","unstructured":"https:\/\/www.fda.gov\/medical-devices\/safety-communications\/fda-warns-against-use-energy-based-devices-perform-vaginal-rejuvenation-or-vaginal-cosmetic."},{"issue":"5","key":"10.1016\/j.maturitas.2020.10.018_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.02.007","article-title":"The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire","volume":"200","author":"Barber","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.maturitas.2020.10.018_bib0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13697137.2014.975197","article-title":"Sexual function after fractional microablative CO(2) laser in women with vulvovaginal atrophy","volume":"18","author":"Salvatore","year":"2015","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.maturitas.2020.10.018_bib0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/GME.0000000000001206","article-title":"Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results","volume":"26","author":"Athanasiou","year":"2018","journal-title":"Menopause (New York, NY)."},{"issue":"3","key":"10.1016\/j.maturitas.2020.10.018_bib0180","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/GME.0000000000000761","article-title":"Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors","volume":"24","author":"Gambacciani","year":"2017","journal-title":"Menopause (New York, NY)."},{"issue":"5","key":"10.1016\/j.maturitas.2020.10.018_bib0185","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00432-018-2614-8","article-title":"Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment","volume":"144","author":"Mothes","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.maturitas.2020.10.018_bib0190","first-page":"225","article-title":"Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device","volume":"68","author":"Vicariotto","year":"2016","journal-title":"Minerva Ginecol."},{"issue":"11","key":"10.1016\/j.maturitas.2020.10.018_bib0195","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1210\/jc.2015-2236","article-title":"Treatment of symptoms of the menopause: an endocrine society clinical practice guideline","volume":"100","author":"Stuenkel","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2020.10.018_bib0200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJWH.S41897","article-title":"Improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy","volume":"5","author":"Minkin","year":"2013","journal-title":"Int. J. Womens Health"},{"issue":"1","key":"10.1016\/j.maturitas.2020.10.018_bib0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/GME.0000000000000955","article-title":"Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women","volume":"25","author":"Cruz","year":"2018","journal-title":"Menopause (New York, NY)."},{"issue":"8","key":"10.1016\/j.maturitas.2020.10.018_bib0210","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/GME.0000000000001333","article-title":"Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial","volume":"26","author":"Politano","year":"2019","journal-title":"Menopause (New York, NY)."},{"issue":"2","key":"10.1016\/j.maturitas.2020.10.018_bib0215","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/lsm.22569","article-title":"Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause","volume":"49","author":"Gaspar","year":"2017","journal-title":"Lasers Surg. Med."},{"issue":"4","key":"10.1016\/j.maturitas.2020.10.018_bib0220","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/GME.0000000000001293","article-title":"Rethinking the techno vagina: a case series of patient complications following vaginal laser treatment for atrophy","volume":"26","author":"Gordon","year":"2019","journal-title":"Menopause (New York, NY)"},{"issue":"11","key":"10.1016\/j.maturitas.2020.10.018_bib0225","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s00066-012-0222-0","article-title":"Radiation-induced morphological changes in the vagina","volume":"188","author":"Kirchheiner","year":"2012","journal-title":"Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al]."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512220304175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512220304175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:48:17Z","timestamp":1778539697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512220304175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":45,"alternative-id":["S0378512220304175"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2020.10.018","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2020.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}